In the second installment of this two-part series, Tableau’s Nate Nichols explores how agentic AI can enhance—not replace—clinicians by providing vital services for care teams, such as real-time transcription, EHR-integrated summaries, and smarter triage, that can free clinicians to focus on patients. The conversation covers patient-side benefits, barriers to adoption, practical first steps for pharma and health systems, and marketing in an agent-first world.
All content for Pharma Council - FutureHealth is the property of Advertising Research Foundation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the second installment of this two-part series, Tableau’s Nate Nichols explores how agentic AI can enhance—not replace—clinicians by providing vital services for care teams, such as real-time transcription, EHR-integrated summaries, and smarter triage, that can free clinicians to focus on patients. The conversation covers patient-side benefits, barriers to adoption, practical first steps for pharma and health systems, and marketing in an agent-first world.
Inclusivity is shaping up to be a mega-trend in healthcare. In the last episode of FutureHealth we discussed why it’s taking center stage in our industry. This time we’re focusing specifically on inclusion in pharma market research and marketing. The ARF Pharma Council recently hosted an event on this subject featuring four research and advertising experts. Each gave a brief description of their work in this area, and then engaged in a discussion. This is an edited version of that...
Pharma Council - FutureHealth
In the second installment of this two-part series, Tableau’s Nate Nichols explores how agentic AI can enhance—not replace—clinicians by providing vital services for care teams, such as real-time transcription, EHR-integrated summaries, and smarter triage, that can free clinicians to focus on patients. The conversation covers patient-side benefits, barriers to adoption, practical first steps for pharma and health systems, and marketing in an agent-first world.
